C3 glomerulopathy and eculizumab: a report on four paediatric cases.

Background: Eculizumab may be used to treat C3-glomerulopathy (C3G), a rare but severe glomerular disease. Diagnosis and Treatment: Patients 1, 2 and 3 were diagnosed with nephritic syndrome with alternative complement pathway activation (low C3, C3Nef-positive) and C3G at the age of 9, 13 and 12 ye...

Descripción completa

Detalles Bibliográficos

Publicado en:	Pediatric Nephrology Vol. 32; no. 6; pp. 1023 - 1029
Autores principales:	Lebreton, Célia, Bacchetta, Justine, Dijoud, Frédérique, Bessenay, Lucie, Fremeaux-Bacchi, Véronique, Sellier-Leclerc, Anne
Formato:	case study research tables/charts Journal Article
Publicado:	Springer Nature Jun2017
Acceso en línea:	Ver este registro en EBSCOhost